
Ep87: Bob Nelsen of ARCH Venture Partners on Biotech Investing
The Long Run with Luke Timmerman
00:00
Celangine Therapy Reviews - Is There a Big Bottleneck?
Fda fta needs more resources to put in place the data science inphra structure. We can't do sirget m points and, you know, what's hyper tension? It's a risk factororortan, an stroke. That's rightren point af. Yet we develop drugs all all day long for hypertension. Why isn't j and j vacine out there? Now?
Transcript
Play full episode